Taivankhuu Terbish

Translation of curative therapy concepts with T cell and cytokine antibody combinations for type 1 diabetes reversal in the IDDM rat

D. Wedekind, S. Lenzen, A. Jörns, 2020, Journal of Molecular Medicine.

TNF-α Antibody Therapy in Combination With the T-Cell–Specific Antibody Anti-TCR Reverses the Diabetic Metabolic State in the LEW.1AR1-iddm Rat

D. Wedekind, S. Lenzen, A. Jörns, 2015, Diabetes.

Anti-TCR therapy combined with fingolimod for reversal of diabetic hyperglycemia by β cell regeneration in the LEW.1AR1-iddm rat model of type 1 diabetes

D. Wedekind, S. Lenzen, A. M. zu Vilsendorf, 2014, Journal of Molecular Medicine.

Diabetes prevention by immunomodulatory FTY720 treatment in the LEW.1AR1-iddm rat despite immune cell activation.

D. Wedekind, S. Lenzen, H. Hedrich, 2010, Endocrinology.

Reversal of diabetes through gene therapy of diabetic rats by hepatic insulin expression via lentiviral transduction.

D. Wedekind, S. Lenzen, M. Elsner, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Induction of Heme Oxygenase-1 Improves the Survival of Pancreas Grafts by Prevention of Pancreatitis After Transplantation

J. Klempnauer, A. M. zu Vilsendorf, T. Becker, 2007, Transplantation.

Anti-TCR therapy combined with fingolimod for reversal of diabetic hyperglycemia by β cell regeneration in the LEW.1AR1-iddm rat model of type 1 diabetes

D. Wedekind, S. Lenzen, H. Hedrich, 2014, Journal of Molecular Medicine.